pembrolizumab,IMM60
merck,Portage
['portage']
$prtg some very good news coming out today at #asco2023. #inkt several target lesions were substantially reduced in size or completely resolved, and a majority of target lesions being clinically stable after twelve weeks, said dr. ian walters. 
I’d like to believe I leave this place a little less lonely, a little more just. - me. Immunology investor when I’m not fighting fascists.